Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

Developing drugs to conquer cancer

Future treatments for suppression of antitumour activity, metastatic melanoma and NSCLC were showcased at ASCO 2012 with some exciting results

EC to implement tougher regulations for medical devices following PIP scandal

But Eucomed raises concerns about pre-market “scrutiny procedure”

- PMLiVE

Janssen and Merck & Co share UK Prix Galien for hepatitis C drugs

Incivo and Victrelis joint winners of Innovative Product Award

- PMLiVE

Janssen and Merck & Co share UK Prix Galien for hepatitis C drugs

Incivo and Victrelis joint winners of Innovative Product Award

Board member Engelbert Tjeenk Willink to leave Boehringer

Replaced by head of established markets Allan Hillgrove

- PMLiVE

Steve Kerridge: ‘If I could change one thing…’

The chairman of Apodi Ltd explains what he would improve within the industry

- PMLiVE

German doctors criticise EU clinical trial reform plans

Could compromise patient safety says German Medical Association

- PMLiVE

Board member Engelbert Tjeenk Willink to leave Boehringer

Replaced by head of established markets Allan Hillgrove

Online personalised cancer medicine resource wins GE grant

My Cancer Genome is one of the first winners of GE Healthcare's Healthy Imagination Cancer Challenge

- PMLiVE

Sanofi launches online diabetes dictionary

Aims to build Diabetapedia into a comprehensive resource of diabetes-related terms and phrases

- PMLiVE

Boehringer Ingelheim expands iPad app portfolio

New company history app featured in PMLiVE’s mobile app listings

One third of consumers use social media for health discussions

US study by PwC says the public finds answers to their wants, needs and preferences in the social space

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links